D003546Chemicals & DrugsD08.811.277.656.262.500D08.811.277.656.300.200790.996487Cysteine EndopeptidasesFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson17671649Sever S, Altintas MM, Nankoe SR, M?ller CC, Ko D, Wei C, Henderson J, del Re EC, Hsing L, Erickson A, Cohen CD, Kretzler M, Kerjaschki D, Rudensky A, Nikolic B, Reiser JThe Journal of clinical investigationProteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest. 2007 Aug; 117(8):2095-104.J Clin Invest2007-08-01T00:00:002007Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.true1Assistant ProfessorAssistant ProfessorJeffreySchneiderJeffrey Schneider350070Schneider, JeffreyAssistant Professor22595989Rhee L, Murphy SF, Kolodziej LE, Grimm WA, Weber CR, Lodolce JP, Chang JE, Bartulis SJ, Messer JS, Schneider JR, Paski S, Nero TM, Boone DLAmerican journal of physiology. Gastrointestinal and liver physiologyExpression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2012 Jul 15; 303(2):G220-7.Am J Physiol Gastrointest Liver Physiol2012-05-17T00:00:002012Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis.22031828Kolodziej LE, Lodolce JP, Chang JE, Schneider JR, Grimm WA, Bartulis SJ, Zhu X, Messer JS, Murphy SF, Reddy N, Turner JR, Boone DLPloS oneTNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions. PLoS One. 2011; 6(10):e26352.PLoS One2011-10-21T00:00:002011TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions.MehmetAltintasMehmet Altintas349147Altintas, MehmetAssociate ProfessorCarlMakiCarl Maki349531Maki, CarlProfessorChangli (David)WeiChangli (David) Wei349720Wei, Changli (David)Associate Professor6Assistant Professor5Associate Professor4Professor0.2146840.01859667research area of0.4394250.057362413subject area for11342637Choppin J, Cohen W, Bianco A, Briand JP, Connan F, Dalod M, Guillet JGJournal of immunology (Baltimore, Md. : 1950)Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation. J Immunol. 2001 May 15; 166(10):6164-9.J Immunol2001-05-15T00:00:002001Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.12239297Cohen WM, Bianco A, Connan F, Camoin L, Dalod M, Lauvau G, Ferri?s E, Culmann-Penciolelli B, van Endert PM, Briand JP, Choppin J, Guillet JGJournal of virologyStudy of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1. J Virol. 2002 Oct; 76(20):10219-25.J Virol2002-10-01T00:00:002002Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.Anatomy and Cell BiologyRush University, Rush Medical Collegetrue1ProfessorProfessorSumantChughSumant S. Chugh349838Chugh, SumantProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate ProfessorInternal Medicine, Division of NephrologyMicrobial Pathogens and Immunity